Registration Dossier
Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 219-417-6 | CAS number: 2432-99-7
Toxicological Summary
Administrative data
Workers - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 1.86 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 75
- Dose descriptor starting point:
- NOAEL
- Value:
- 79 mg/kg bw/day
- Modified dose descriptor starting point:
- NOAEC
- Value:
- 139 mg/m³
- Explanation for the modification of the dose descriptor starting point:
Conversion into an inhalatory rat NOAEC by dividing by 0.38 m3/kg (8-hour respiratory volume in the rat)
*No correction for inhalatory and oral absorption rates (considered to be 100 % because 11-aminoundecanoic acid is well absorbed by both routes)
*Correction for activity driven differences in respiratory volume in workers compared to individuals at rest (6.7 m3/10 m3)
*Corrected dose descriptor:NOAEC (worker, 8 h)= 79 x 1/0.38 x 6.7/10 = 139 mg/m3
- AF for dose response relationship:
- 1
- AF for differences in duration of exposure:
- 6
- AF for interspecies differences (allometric scaling):
- 2.5
- AF for other interspecies differences:
- 1
- AF for intraspecies differences:
- 5
- AF for the quality of the whole database:
- 1
- AF for remaining uncertainties:
- 1
Acute/short term exposure
- Hazard assessment conclusion:
- hazard unknown but no further hazard information necessary as no exposure expected
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- hazard unknown but no further hazard information necessary as no exposure expected
Acute/short term exposure
- Hazard assessment conclusion:
- hazard unknown but no further hazard information necessary as no exposure expected
DNEL related information
Workers - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.26 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 300
- Dose descriptor starting point:
- NOAEL
- Value:
- 79 mg/kg bw/day
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 0.26 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
DNEL Value based on NOAEL OECD 421 :
79 x 1 x 1/(2.5 x 4 x 5 x 6 x 1 x 1) = 0.26 mg/kg bw
- AF for dose response relationship:
- 1
- AF for differences in duration of exposure:
- 6
- AF for interspecies differences (allometric scaling):
- 2.5
- AF for other interspecies differences:
- 4
- AF for intraspecies differences:
- 5
- AF for the quality of the whole database:
- 1
- AF for remaining uncertainties:
- 1
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
Workers - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- no hazard identified
Additional information - workers
- Step 1: Selection of the relevant dose descriptor:
- Step 2: Modification of the starting point:
- Step 3: Assessment factors:
- Step 4: DNEL derivation:
For acute effects, no significant effects that would justify DNEL derivation were observed in the corresponding toxicity studies.
For systemic effects, DNEL derivation was performed following the method proposed in the ECHA Guidance on information requirements and chemical safety assessment, Chapter R.8.
1. Long term exposure-systemic toxicity
1.1 Inhalation DNEL(workers)
Occupational exposure to 11 -aminoundecanoic acid may occur mainly by inhalation of particles, therefore we consider the inhalation route as the most relevant for DNEL derivation.
Of all repeated dose toxicity studies in rats, the OECD TG 421 (reproductive/developmental screening) study (CIT, 2008) is selected for DNEL derivation as it is the study where the lowest NOAEL was observed among the repeated dose toxicity studies data set with 11-aminoundecanoic acid, and because effects on kidneys, considered as the critical effect with a threshold mode of action, were also observed in this study.
*NOAEL (parental toxicity) = 1250 ppm, equivalent to79 mg/kg/day
*No reproductive effects but renal effects were observed in the parents (histopathological findings).
*Conversion into an inhalatory rat NOAEC by dividing by 0.38 m3/kg (8-hour respiratory volume in the rat)
*No correction for inhalatory and oral absorption rates (considered to be 100 % because 11-aminoundecanoic acid is well absorbed by both routes)
*Correction for activity driven differences in respiratory volume in workers compared to individuals at rest (6.7 m3/10 m3)
*Corrected dose descriptor:NOAEC (worker, 8 h)= 79 x 1/0.38 x 6.7/10 = 139 mg/m3
*Interspecies : no allometric scaling factor is applied because an oral-to-inhalation route extrapolation is performed. However, a factor of 2.5 to correct for differences other than differences in metabolic rate is applied.
*Intraspecies : the default assessment factor of 5 is applied.
* Differences in exposure duration: as the exposure in rats was 54 days, a factor of 6 for subacute-to-chronic extrapolation is applied.
*Dose-response relationship: a factor of 1 is applied due to the use of a NOAEL as dose descriptor and the low toxicity of the test substance.
*Quality of whole database: a factor of 1 is applied based on the good quality of the whole database.
*Global assessment factor: 2.5 x 5 x 6 x 1 x 1 = 75
Worker DNEL (long term, systemic effects)= 79 x 1/0.38 x 6.7/10 x 1/75 = 1.86 mg/m3
2. Dermal DNEL (workers)
Occupational exposure to 11 -aminoundecanoic acid may also occur by dermal exposure. Although no dermal repeated dose toxicity studies is available as well as no information on dermal absorption, we derived a dermal DNEL based on the Oral NOAEL selected for the derivation of the inhalation DNEL.
Step 1) Relevant dose-descriptor
* NOAEL, rats= (parental toxicity) =1250 ppm, equivalent to79 mg/kg/day
Step 2)Modification of starting point:
* Correction for oral to dermal absorption :
11 -aminoundecanoic acid has a low octanol partition coefficient (log Kow=0.16) which predicts a low dermal absorption. However as no dermal penetration study is available we consider 100% absorbsion as a worst case (=1).
No difference in dermal absorption is expected between rats and humans, no correction factor will be applied.
Step 3) Assessment factors
* Interspecies: 2.5 x 4
* Intraspecies : 5
* Exposure duration : 6 (as the exposure in rats was 54 days, a factor of 6 for subacute-to-chronic extrapolation is applied).
* Dose response:1
* Quality of database:1
DNEL Value based on NOAEL OECD 421 :
79 x 1 x 1/(2.5 x 4 x 5 x 6 x 1 x 1) = 0.26 mg/kg bw
Oral route
The oral route of exposure is not relevant to workers.
General Population - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.45 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 150
- Dose descriptor starting point:
- NOAEL
- Value:
- 79 mg/kg bw/day
- Modified dose descriptor starting point:
- NOAEC
- Value:
- 67.94 mg/m³
- Explanation for the modification of the dose descriptor starting point:
see discussion below
79 mg/kg/day x1/1.15=67.94 mg/m3
- AF for dose response relationship:
- 1
- AF for differences in duration of exposure:
- 6
- AF for interspecies differences (allometric scaling):
- 2.5
- AF for other interspecies differences:
- 4
- AF for intraspecies differences:
- 10
- AF for remaining uncertainties:
- 1
Acute/short term exposure
- Hazard assessment conclusion:
- hazard unknown but no further hazard information necessary as no exposure expected
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- hazard unknown but no further hazard information necessary as no exposure expected
Acute/short term exposure
- Hazard assessment conclusion:
- hazard unknown but no further hazard information necessary as no exposure expected
DNEL related information
General Population - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.13 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 600
- Dose descriptor starting point:
- NOAEL
- Value:
- 79 mg/kg bw/day
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 79 mg/kg bw/day
- AF for dose response relationship:
- 1
- AF for differences in duration of exposure:
- 6
- AF for interspecies differences (allometric scaling):
- 2.5
- AF for other interspecies differences:
- 4
- AF for intraspecies differences:
- 10
- AF for the quality of the whole database:
- 1
- AF for remaining uncertainties:
- 1
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- hazard unknown but no further hazard information necessary as no exposure expected
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
General Population - Hazard via oral route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.13 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 600
- Dose descriptor starting point:
- NOAEL
- Value:
- 79 mg/kg bw/day
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 79 mg/kg bw/day
- AF for dose response relationship:
- 1
- AF for differences in duration of exposure:
- 6
- AF for interspecies differences (allometric scaling):
- 2.5
- AF for other interspecies differences:
- 4
- AF for intraspecies differences:
- 10
- AF for the quality of the whole database:
- 1
- AF for remaining uncertainties:
- 1
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
General Population - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- low hazard (no threshold derived)
Additional information - General Population
Occupational exposure to 11 -aminoundecanoic acid is the most relevant potential safety concern under the conditions of use of the substance. There is no direct consumer use of 11 -aminoundecanoic acid, Food contact materials made of polyamide 11 contain low residual levels of 11-aminoundecanoic acid (<100 ppm) and are subject to very strict regulations, therefore no DNEL derivation for general population was deemed necessary.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
